Attendees of the symposium will gain an understanding of novel molecular diagnostics for risk stratification of sudden cardiac death, diagnostic and treatment protocols for special populations of patients including athletes and pregnant patients as well as new therapies in cardiac ablation, surgical intervention, and cardiac device management for patients with congestive heart failure, atrial fibrillation and ventricular tachycardia.
To learn more about this activity, click on the "learn more" button below.
Omni Providence Hotel
1 West Exchange Street
Antony Chu, MD, FACC, FHRS, FAHA, FACP
- Identify novel strategies for risk stratification of sudden cardiac death in a diverse patient population to include athletes, the young and pregnancy
- Identify new therapies for prevention of thromboembolic stroke in patients with atrial fibrillation
- Discuss new cardiac device technologies available for prevention of sudden cardiac death and treatment of congestive heart failure
- Physician Assistants
- Nurse Practitioners
- Residents and Fellows specializing in Anesthesiology, Cardiac Surgery, Cardiology, Electrophysiology, Emergency Medicine, Family Medicine, OB/GYN, Critical Care Medicine, Internal Medicine, and Primary Care